Our previous study demonstrated that targeting CTSS suppressed proinflammatory cytokine secretion and promoted anti-inflammatory cytokine secretion, protecting neurons from oxaliplatin-induced peripheral neuropathy, indicating that the inhibition of CTSS reduced tissue inflammation [18]. The gene discussed is CTSS; the disease is peripheral neuropathy.